De novo HNF1A mutation of young maturity-onset diabetes 3 of a young girl—Case report

2Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Young maturity-onset diabetes of the young type3(MODY3) as a special type of diabetes, the probability of diagnosis is low. This article reports on a case and reviews the relevant knowledge of the disease. We report an 11-year-and-11-month-old girl whose grandmother died from diabetic complications while the rest of the families were non-diabetes. The proband was initially treated with insulin and metformin but the threatment proved inefficient. After an exome-targeted capture sequencing test, she was diagnosed with mature-onset diabetes of young type 3 (MODY3), and sulfonylureas make sense. The key to mody treatment is a correct and timely diagnosis, which contributes to helping patients overcome the problems of MODY3, especially for blood sugar control.

Author supplied keywords

Cite

CITATION STYLE

APA

Peng, H., Li, J., & Wang, Z. (2023). De novo HNF1A mutation of young maturity-onset diabetes 3 of a young girl—Case report. BMC Endocrine Disorders, 23(1). https://doi.org/10.1186/s12902-023-01293-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free